These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 9216829)

  • 1. (1 alpha, 2 beta, 3 beta, 4 alpha)-1,2-bis[N-propyl-N-(4-phenoxybenzyl) amino]carbonyl]cyclobutane-3,4-dicarboxylic acid (A-87049): a novel potent squalene synthase inhibitor.
    Fung AK; Baker WR; Fakhoury S; Stein HH; Cohen J; Donner BG; Garvey DS; Spina KP; Rosenberg SH
    J Med Chem; 1997 Jul; 40(14):2123-5. PubMed ID: 9216829
    [No Abstract]   [Full Text] [Related]  

  • 2. RPR 107393, a potent squalene synthase inhibitor and orally effective cholesterol-lowering agent: comparison with inhibitors of HMG-CoA reductase.
    Amin D; Rutledge RZ; Needle SN; Galczenski HF; Neuenschwander K; Scotese AC; Maguire MP; Bush RC; Hele DJ; Bilder GE; Perrone MH
    J Pharmacol Exp Ther; 1997 May; 281(2):746-52. PubMed ID: 9152381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclopentanedi- and tricarboxylic acids as squalene synthase inhibitors: syntheses and evaluation.
    Shen W; Garvey DS; Cohen J; Stein H; Rosenberg SH
    Bioorg Med Chem Lett; 1998 Apr; 8(8):891-6. PubMed ID: 9871507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel tricyclic compounds as squalene synthase inhibitors.
    Ichikawa M; Ohtsuka M; Ohki H; Haginoya N; Itoh M; Sugita K; Usui H; Suzuki M; Terayama K; Kanda A
    Bioorg Med Chem; 2012 May; 20(9):3072-93. PubMed ID: 22464687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and activity of a novel series of 3-biarylquinuclidine squalene synthase inhibitors.
    Brown GR; Clarke DS; Foubister AJ; Freeman S; Harrison PJ; Johnson MC; Mallion KB; McCormick J; McTaggart F; Reid AC; Smith GJ; Taylor MJ
    J Med Chem; 1996 Jul; 39(15):2971-9. PubMed ID: 8709131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of atrop fixed alkoxy-aminobenzhydrol derivatives: novel, highly potent and orally efficacious squalene synthase inhibitors.
    Ichikawa M; Yokomizo A; Itoh M; Haginoya N; Sugita K; Usui H; Terayama K; Kanda A
    Bioorg Med Chem; 2011 Sep; 19(17):5207-24. PubMed ID: 21802309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The squalestatins: decarboxy and 4-deoxy analogues as potent squalene synthase inhibitors.
    Chan C; Andreotti D; Cox B; Dymock BW; Hutson JL; Keeling SE; McCarthy AD; Procopiou PA; Ross BC; Sareen M; Scicinski JJ; Sharratt PJ; Snowden MA; Watson NS
    J Med Chem; 1996 Jan; 39(1):207-16. PubMed ID: 8568810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid-lowering properties of TAK-475, a squalene synthase inhibitor, in vivo and in vitro.
    Nishimoto T; Amano Y; Tozawa R; Ishikawa E; Imura Y; Yukimasa H; Sugiyama Y
    Br J Pharmacol; 2003 Jul; 139(5):911-8. PubMed ID: 12839864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenoxypropylamines: a new series of squalene synthase inhibitors.
    Brown GR; Butlin RJ; Chapman S; Eakin MA; Foubister AJ; Freeman S; Griffiths D; Harrison PJ; Johnson MC; Mallion KB
    J Med Chem; 1995 Oct; 38(21):4157-60. PubMed ID: 7473541
    [No Abstract]   [Full Text] [Related]  

  • 10. The squalestatins: inhibitors of squalene synthase. Enzyme inhibitory activities and in vivo evaluation of C3-modified analogues.
    Procopiou PA; Cox B; Kirk BE; Lester MG; McCarthy AD; Sareen M; Sharratt PJ; Snowden MA; Spooner SJ; Watson NS; Widdowson J
    J Med Chem; 1996 Mar; 39(7):1413-22. PubMed ID: 8691471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of N-(beta-D-glucopyranosyl) monoamides of dicarboxylic acids as potential inhibitors of glycogen phosphorylase.
    Czifrák K; Hadady Z; Docsa T; Gergely P; Schmidt J; Wessjohann L; Somsák L
    Carbohydr Res; 2006 Jun; 341(8):947-56. PubMed ID: 16564511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syntheses and biological evaluation of novel quinuclidine derivatives as squalene synthase inhibitors.
    Ishihara T; Kakuta H; Moritani H; Ugawa T; Sakamoto S; Tsukamoto S; Yanagisawa I
    Bioorg Med Chem; 2003 May; 11(11):2403-14. PubMed ID: 12735986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orally active squalene synthase inhibitors: bis((acyloxy)alkyl) prodrugs of the alpha-phosphonosulfonic acid moiety.
    Dickson JK; Biller SA; Magnin DR; Petrillo EW; Hillyer JW; Hsieh DC; Lan SJ; Rinehart JK; Gregg RE; Harrity TW; Jolibois KG; Kalinowski SS; Kunselman LK; Mookhtiar KA; Ciosek CP
    J Med Chem; 1996 Feb; 39(3):661-4. PubMed ID: 8576906
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of cholesterol synthesis by squalene synthase inhibitors does not induce myotoxicity in vitro.
    Flint OP; Masters BA; Gregg RE; Durham SK
    Toxicol Appl Pharmacol; 1997 Jul; 145(1):91-8. PubMed ID: 9221828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of novel 4,1-benzoxazepine derivatives as squalene synthase inhibitors and their inhibition of cholesterol synthesis.
    Miki T; Kori M; Mabuchi H; Tozawa R; Nishimoto T; Sugiyama Y; Teshima K; Yukimasa H
    J Med Chem; 2002 Sep; 45(20):4571-80. PubMed ID: 12238936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clavaric acid and steroidal analogues as Ras- and FPP-directed inhibitors of human farnesyl-protein transferase.
    Lingham RB; Silverman KC; Jayasuriya H; Kim BM; Amo SE; Wilson FR; Rew DJ; Schaber MD; Bergstrom JD; Koblan KS; Graham SL; Kohl NE; Gibbs JB; Singh SB
    J Med Chem; 1998 Nov; 41(23):4492-501. PubMed ID: 9804689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid-lowering (hetero)aromatic tetrahydro-1,4-oxazine derivatives with antioxidant and squalene synthase inhibitory activity.
    Kourounakis AP; Charitos C; Rekka EA; Kourounakis PN
    J Med Chem; 2008 Sep; 51(18):5861-5. PubMed ID: 18754614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and optimization of tetrahydro-2H-3-benzazepin-2-ones as squalene synthase inhibitors.
    Griebenow N; Flessner T; Buchmueller A; Raabe M; Bischoff H; Kolkhof P
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2554-8. PubMed ID: 21396815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of 4H,6H-[2]benzoxepino[4,5-c][1,2]oxazoles as novel squalene synthase inhibitors.
    Griebenow N; Buchmueller A; Kolkhof P; Schamberger J; Bischoff H
    Bioorg Med Chem Lett; 2011 Jun; 21(12):3648-53. PubMed ID: 21576018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substituted pyrrolidine-2,4-dicarboxylic acid amides as potent dipeptidyl peptidase IV inhibitors.
    Tsai TY; Coumar MS; Hsu T; Hsieh HP; Chien CH; Chen CT; Chang CN; Lo YK; Wu SH; Huang CY; Huang YW; Wang MH; Wu HY; Lee HJ; Chen X; Chao YS; Jiaang WT
    Bioorg Med Chem Lett; 2006 Jun; 16(12):3268-72. PubMed ID: 16581245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.